The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 345:1055-1057 October 4, 2001 Number 14
NextNext

An Epidemic of Urinary Tract Infections?

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Manges, A. R.
-PubMed Citation
Community-acquired urinary tract infections occur mostly in women, are generally caused by Escherichia coli, and are among the most common bacterial infections. For the past two decades, trimethoprim–sulfamethoxazole or trimethoprim alone has been used widely as empirical therapy for E. coli urinary tract infection. However, in the United States, resistance to trimethoprim–sulfamethoxazole among E. coli isolates from persons with community-acquired urinary tract infections has increased substantially over the past decade, with a prevalence that now exceeds 20 percent in many parts of the country.1 The prevalence of such resistance is substantially higher in the West (22 percent) than in the . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.